PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
3,071,257
Share change
-177,569
Total reported value
$60,972,550
Price per share
$19.82
Number of holders
44
Value change
-$2,717,050
Number of buys
24
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q3 2016

As of 30 Sep 2016, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,071,257 shares. The largest 10 holders included Moors & Cabot, Inc., Uniplan Investment Counsel, Inc., RENAISSANCE TECHNOLOGIES LLC, Tieton Capital Management, LLC, VANGUARD GROUP INC, CRAWFORD INVESTMENT COUNSEL INC, Wall Street Access Asset Management, LLC, Granite Investment Partners, LLC, North Star Investment Management Corp., and RBF Capital, LLC. This page lists 44 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.